Prof. Dr. Aysun Soysal

Prolonged Median Motor Distal Latency: What If not Carpal Tunnel Syndrome but Acute Inflammatory Demyelinating Polyradiculoneuropathy?

Neurological Sciences and Neurophysiology, 2024

DOI 10.4103/nsn.nsn_117_24 Frei zugänglicher VolltextQuelle: ORCID

Routine CSF parameters as predictors of disease course in multiple sclerosis: An MSBase cohort study

Journal of Neurology Neurosurgery and Psychiatry, 2024

DOI 10.1136/jnnp-2023-333307 PMID 38569872 8 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

The impact of COVID-19 infection on multiple sclerosis disease course across 12 countries: a propensity-score-matched cohort study

Therapeutic Advances in Neurological Disorders, 2024

DOI 10.1177/17562864241278496 PMID 39525878 5 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries

Lancet Child and Adolescent Health, 2024

DOI 10.1016/s2352-4642(24)00047-6 PMID 38547883 34 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Effectiveness of Disease-Modifying Treatment on Spinal Cord Lesion Formation in Relapse-Onset Multiple Sclerosis: An MSBase Registry Study

CNS Drugs, 2024

DOI 10.1007/s40263-024-01115-x PMID 39242483 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

3018 A multi-centre longitudinal study analysing disease modifying therapy prescribing patterns during the COVID-19 pandemic

BMJ Neurology Open, 2024

DOI 10.1136/bmjno-2024-anzan.45 Frei zugänglicher VolltextQuelle: OpenAlex

A Journey from Transient Neurological Deficits to a Genetic Diagnosis: CADASIL Case Report

Neuroscience Applied, 2024

DOI 10.1016/j.nsa.2024.104717 Frei zugänglicher VolltextQuelle: OpenAlex

From diagnosis to recovery: a rare case of opsoclonus-myoclonus syndrome in an adult successfully treated with IVIg

Neuroscience Applied, 2024

DOI 10.1016/j.nsa.2024.104345 Frei zugänglicher VolltextQuelle: OpenAlex

A plain language summary on the effectiveness of cladribine tablets compared with other oral treatments for multiple sclerosis: results from the MSBase registry

Neurodegenerative Disease Management, 2023

DOI 10.2217/nmt-2023-0005 PMID 37287269 Frei zugänglicher VolltextQuelle: ORCID

Comparative effectiveness in multiple sclerosis: A methodological comparison

Multiple Sclerosis Journal, 2023

DOI 10.1177/13524585231151394 PMID 36800908 4 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry

Multiple Sclerosis Journal, 2023

DOI 10.1177/13524585221137502 PMID 36433775 32 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Disability accrual in primary and secondary progressive multiple sclerosis

Journal of Neurology Neurosurgery and Psychiatry, 2023

DOI 10.1136/jnnp-2022-330726 PMID 37068931 6 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis

Multiple Sclerosis Journal, 2023

DOI 10.1177/13524585231151951 PMID 36851894 15 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Enhancement of motor skill acquisition by intermittent theta burst stimulation: a pilot study

Acta Neurologica Belgica, 2023

DOI 10.1007/s13760-022-02155-0 PMID 36508110 2 Zitationen (Europe PMC) Quelle: ORCID

External validation of a clinical prediction model in multiple sclerosis

Multiple Sclerosis Journal, 2023

DOI 10.1177/13524585221136036 PMID 36448727 3 Zitationen (Europe PMC) Quelle: ORCID

Non-invasive brain stimulation on clinical symptoms in multiple sclerosis patients: A systematic review and meta-analysis

Multiple Sclerosis and Related Disorders, 2023

DOI 10.1016/j.msard.2023.104927 PMID 37595371 22 Zitationen (Europe PMC) Quelle: ORCID

Predictors of treatment switching in the Big Multiple Sclerosis Data Network

Frontiers in Neurology, 2023

DOI 10.3389/fneur.2023.1274194 PMID 38187157 9 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Retrospective analysis of effectiveness of fingolimod in real life setting in Turkey (REFINE)

Turkish Journal of Medical Sciences, 2023

DOI 10.55730/1300-0144.5588 PMID 36945929 Frei zugänglicher VolltextQuelle: ORCID

Risk of secondary progressive multiple sclerosis after early worsening of disability

Journal of Neurology Neurosurgery and Psychiatry, 2023

DOI 10.1136/jnnp-2023-331748 PMID 37414538 14 Zitationen (Europe PMC) Quelle: ORCID

Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis

JAMA Neurology, 2023

DOI 10.1001/jamaneurol.2023.1625 PMID 37307006 60 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis

Neurological Sciences, 2023

DOI 10.1007/s10072-023-06608-z PMID 36689010 17 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

Brain, 2023

DOI 10.1093/brain/awad218 PMID 37369086 22 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Trigeminal Neuralgia Associated with Vagus Nerve Stimulation: A Case Presentation and Literature Review

Archives of Epilepsy, 2023

DOI 10.4274/archepilepsy.2023.23101 Frei zugänglicher VolltextQuelle: ORCID

Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis

European Journal of Neurology, 2023

DOI 10.1111/ene.15706 PMID 36692895 8 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis

JAMA Neurology, 2023

DOI 10.1001/jamaneurol.2023.1184 PMID 37437240 61 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

The Comparison of General Characteristics and Early and Late Post-intervention Results in Patients With Trigeminal Neuralgia Secondary to Multiple Sclerosis and Idiopathic Trigeminal Neuralgia Treated With Radiofrequency Thermocoagulation

Cureus, 2023

DOI 10.7759/cureus.44810 PMID 37809255 9 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

MSMilan2023 – Oral Presentations

Multiple Sclerosis Journal, 2023

DOI 10.1177/13524585231196191 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

TH-153. Clinical and electrophysiological characteristics of Guillain-Barré Syndrome before and during the pandemic: The multicenter Istanbul study

Clinical Neurophysiology, 2022

DOI 10.1016/j.clinph.2022.07.333 Quelle: OpenAlex

Autoimmune encephalitis and paraneoplastic syndromes in Turkey: a multi-centre study

Neurological Sciences, 2022

DOI 10.1007/s10072-022-05955-7 PMID 35211811 4 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Confirmed disability progression as a marker of permanent disability in multiple sclerosis

European Journal of Neurology, 2022

DOI 10.1111/ene.15406 PMID 35582938 10 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis

Neurology, 2022

DOI 10.1212/wnl.0000000000201029 PMID 35977837 49 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Early predictors of disability in paediatric multiple sclerosis: evidence from a multi-national registry

Journal of Neurology Neurosurgery and Psychiatry, 2022

DOI 10.1136/jnnp-2022-329713 PMID 36180218 4 Zitationen (Europe PMC) Quelle: ORCID

Four-year Experience of Intravenous and Endovascular Treatment in Acute Ischemic Stroke: A Single Center Study,Akut İskemik İnmede İntravenöz ve Endovasküler Tedavi Deneyimlerimiz: Dört Yıllık Tek Merkez Çalışma

Turk Noroloji Dergisi, 2022

DOI 10.4274/tnd.2022.33733 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

Ischemic stroke due to spontaneous reversible extra-cranial internal carotid artery vasospasm: A case report

Neurology Asia, 2022

DOI 10.54029/2022vmm 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

Machine-Learning-Based Prediction of Disability Progression in Multiple Sclerosis: An Observational, International, Multi-Center Study

Ssrn, 2022

DOI 10.2139/ssrn.4245135 Quelle: ORCID

Machine-learning-based prediction of disability progression in multiple sclerosis: an observational, international, multi-center study

Medrxiv, 2022

DOI 10.1101/2022.09.08.22279617 Frei zugänglicher VolltextQuelle: ORCID

Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS

Multiple Sclerosis Journal, 2022

DOI 10.1177/13524585221084577 PMID 35373638 4 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Predictive Analysis of Errors During Robot-Mediated Gamified Training

IEEE International Conference on Rehabilitation Robotics, 2022

DOI 10.1109/icorr55369.2022.9896589 PMID 36176135 Frei zugänglicher VolltextQuelle: ORCID

Restless legs syndrome after acute ıschemic stroke and ıts relation to lesion location

Sleep and Biological Rhythms, 2022

DOI 10.1007/s41105-022-00401-9 PMID 38468622 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

The minnesota manual dexterity test as a bimanual performance measure in people with multiple sclerosis

Multiple Sclerosis and Related Disorders, 2022

DOI 10.1016/j.msard.2022.103943 PMID 35738113 10 Zitationen (Europe PMC) Quelle: ORCID

Real-world Comparative Effectiveness and Persistence of Cladribine Tablets and Other Oral Disease-Modifying Treatments for Multiple Sclerosis from GLIMPSE: Results from the MSBase Registry (P12-4.003)

Neurology, 2022

DOI 10.1212/wnl.98.18_supplement.1373 4 Zitationen (OpenAlex) Quelle: OpenAlex

Enjeksiyon Nöropatisi Olgularında Siyatik Sinir Tutulumunun ve Derecesinin Değerlendirilmesi

Dicle Medical Journal / Dicle Tip Dergisi, 2022

DOI 10.5798/dicletip.1086306 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

Early Predictors of Disability in Paediatric Multiple Sclerosis: Evidence from a Multi-National Registry (P17-4.001)

Neurology, 2022

DOI 10.1212/wnl.98.18_supplement.2668 Quelle: OpenAlex

The Complex Genetic Landscape of Hereditary Ataxias in Turkey and Implications in Clinical Practice

Movement Disorders, 2021

DOI 10.1002/mds.28518 PMID 33624863 13 Zitationen (Europe PMC) Quelle: OpenAlex

Central nervous system vasculitis due to an endemic zoonosis in turkey; tularemia,Ülkemizde endemik bir zoonoz nedeni; tularemi?ye bağli santral sinir sistemi vasküliti

Noropsikiyatri Arsivi, 2021

DOI 10.29399/npa.23491 PMID 33795957 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Determinants of therapeutic lag in multiple sclerosis

Multiple Sclerosis Journal, 2021

DOI 10.1177/1352458520981300 PMID 33423618 4 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis

Multiple Sclerosis Journal, 2021

DOI 10.1177/1352458520926955 PMID 32538713 11 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Fluctuating Pupil-sparing Oculomotor Nerve Palsy with Intracranial Spontaneous Dissecting Aneurysm,İntrakraniyal Spontan Dissekan Anevrizmaya Bağlı Fluktuasyon Gösteren Okulomotor Sinir Felci

Turk Noroloji Dergisi, 2021

DOI 10.4274/tnd.2021.47700 Frei zugänglicher VolltextQuelle: ORCID

Investigation of oxidative stress in relapse and remission periods of patients with relapsing-remitting multiple sclerosis

Neurological Sciences and Neurophysiology, 2021

DOI 10.4103/nsn.nsn_142_20 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

Long-term outcomes in patients presenting with optic neuritis: Analyses of the MSBase registry

Journal of the Neurological Sciences, 2021

DOI 10.1016/j.jns.2021.118067 PMID 34537678 12 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID